MedTrace Logo

Psychotherapy of Generalized Anxiety Disorder

NCT00118001 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-04-01

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of worry exposure with the effects of applied relaxation in patients with generalized anxiety disorder.

Conditions

  • Anxiety Disorders

Interventions

BEHAVIORAL

Worry exposure

BEHAVIORAL

Applied relaxation

Sponsors & Collaborators

  • German Research Foundation

    lead OTHER

Principal Investigators

  • Jürgen Hoyer, PhD · Technische Universität Dresden

  • Eni S Becker, PhD · University of Nijmegen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Completion
2006-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118001 on ClinicalTrials.gov